ICC F15 - Diabetic retinopathy. Where do we stand?

Intermediate

Diabetic retinopathy (DR) and diabetic macular edema (DME) are leading causes of blindness in the working-age population of most developed countries. The increasing number of individuals with diabetes worldwide suggests that DR and DME will continue to be major contributors to vision loss and associated functional impairment for years to come. We provide an overview of clinical risk factors, pathophysiology and diagnostic modalities and will establish a treatment and follow-up plan. Several recent multicenter randomized clinical trials have been completed and are changing the approach to this disorder. The role of traditional laser photocoagulation, vitrectomy and effective new intravitreal pharmacotherapy options will be discussed and will include a glimpse into the (near) future.